Stifel Nicolaus Issues Pessimistic Forecast for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGL) had its price target dropped by Stifel Nicolaus from $7.00 to $2.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price target suggests a potential upside of 6.95% from the company’s current price.

Several other research analysts have also commented on the stock. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday. Citigroup reissued a “sell” rating and set a $2.50 price target (down from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. Barclays cut their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday. Evercore ISI reduced their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Finally, William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $7.03.

agilon health Price Performance

agilon health stock traded down $0.29 during midday trading on Tuesday, hitting $1.87. 3,957,468 shares of the company’s stock were exchanged, compared to its average volume of 4,960,215. The company has a market cap of $769.47 million, a P/E ratio of -1.99 and a beta of 0.60. agilon health has a 52-week low of $1.80 and a 52-week high of $13.76. The stock has a 50-day moving average price of $3.22 and a two-hundred day moving average price of $4.95. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. During the same period last year, the firm earned ($0.06) earnings per share. On average, equities research analysts forecast that agilon health will post -0.32 earnings per share for the current year.

Insider Activity

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is owned by insiders.

Hedge Funds Weigh In On agilon health

Hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the last quarter. Capital International Investors lifted its stake in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after buying an additional 9,263,296 shares during the period. Citigroup Inc. grew its position in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the period. AQR Capital Management LLC increased its stake in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in agilon health by 18.7% in the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock worth $7,252,000 after purchasing an additional 174,883 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.